4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-19-041708
Chief Medical Officer sold 17,500 shares at an average $20.29 ($355,011)
- Chief Medical Officer acquired 6,511 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ho Carole Chief Medical Officer | 2019-07-08 | Option exercise | +2,604 | $5.28 | $13,749 | 6,685 | D |
| Ho Carole Chief Medical Officer | 2019-07-08 | Sale | −2,604 | $19.93 | $51,898 | 4,081 | D |
| Ho Carole Chief Medical Officer | 2019-07-08 | Option exercise | +3,907 | $5.28 | $20,629 | 7,988 | D |
| Ho Carole Chief Medical Officer | 2019-07-08 | Sale | −3,907 | $20.55 | $80,289 | 4,081 | D |
| Ho Carole Chief Medical Officer | 2019-07-08 | Sale | −9,889 | $20.21 | $199,857 | 81,034 | I |
| Ho Carole Chief Medical Officer | 2019-07-08 | Sale | −1,100 | $20.88 | $22,968 | 79,934 | I |
| Derivatives | |||||||
| Ho Carole Chief Medical Officer | 2019-07-08 | Option exercise · Stock Option (right to buy) | −2,604 | 92,565 | D | ||
| Ho Carole Chief Medical Officer | 2019-07-08 | Option exercise · Stock Option (right to buy) | −3,907 | 78,126 | D | ||
| Open-market sales · 17,500 sh · avg $20.29 · $355,011 | |||||||
Loading xslF345X03/doc4.xml…